[go: up one dir, main page]

FR2830762B1 - USE OF A PROTEIN FROM THE CRMPS FAMILY FOR THE TREATMENT OF IMMUNE SYSTEM-RELATED DISEASES - Google Patents

USE OF A PROTEIN FROM THE CRMPS FAMILY FOR THE TREATMENT OF IMMUNE SYSTEM-RELATED DISEASES

Info

Publication number
FR2830762B1
FR2830762B1 FR0113342A FR0113342A FR2830762B1 FR 2830762 B1 FR2830762 B1 FR 2830762B1 FR 0113342 A FR0113342 A FR 0113342A FR 0113342 A FR0113342 A FR 0113342A FR 2830762 B1 FR2830762 B1 FR 2830762B1
Authority
FR
France
Prior art keywords
crmps
family
protein
treatment
immune system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0113342A
Other languages
French (fr)
Other versions
FR2830762A1 (en
Inventor
Pascale Giraudon
Marie Francoise Belin
Christophe Malcus
Pierre Colas
Jean Christophe Antoine
Jerome Honnorat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0113342A priority Critical patent/FR2830762B1/en
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to PCT/FR2002/003056 priority patent/WO2003022298A2/en
Priority to AT02774915T priority patent/ATE517629T1/en
Priority to AU2002341090A priority patent/AU2002341090A1/en
Priority to CA002461692A priority patent/CA2461692A1/en
Priority to US10/488,554 priority patent/US7820375B2/en
Priority to JP2003526426A priority patent/JP4499414B2/en
Priority to EP02774915A priority patent/EP1435993B1/en
Publication of FR2830762A1 publication Critical patent/FR2830762A1/en
Application granted granted Critical
Publication of FR2830762B1 publication Critical patent/FR2830762B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR0113342A 2001-09-07 2001-10-16 USE OF A PROTEIN FROM THE CRMPS FAMILY FOR THE TREATMENT OF IMMUNE SYSTEM-RELATED DISEASES Expired - Fee Related FR2830762B1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR0113342A FR2830762B1 (en) 2001-10-16 2001-10-16 USE OF A PROTEIN FROM THE CRMPS FAMILY FOR THE TREATMENT OF IMMUNE SYSTEM-RELATED DISEASES
AT02774915T ATE517629T1 (en) 2001-09-07 2002-09-09 USE OF A PROTEIN OF THE CRMP FAMILY TO TREAT IMMUNE SYSTEM DISEASES
AU2002341090A AU2002341090A1 (en) 2001-09-07 2002-09-09 Use of a protein of the crmp family for treating diseases related to the immune system
CA002461692A CA2461692A1 (en) 2001-09-07 2002-09-09 Use of a protein of the crmp family for treating diseases related to the immune system
PCT/FR2002/003056 WO2003022298A2 (en) 2001-09-07 2002-09-09 Use of a protein of the crmp family for treating diseases related to the immune system
US10/488,554 US7820375B2 (en) 2001-09-07 2002-09-09 Use of a protein of the CRMP family for treating diseases related to the immune system
JP2003526426A JP4499414B2 (en) 2001-09-07 2002-09-09 Use of CRMP family proteins to treat diseases related to the immune system
EP02774915A EP1435993B1 (en) 2001-09-07 2002-09-09 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0113342A FR2830762B1 (en) 2001-10-16 2001-10-16 USE OF A PROTEIN FROM THE CRMPS FAMILY FOR THE TREATMENT OF IMMUNE SYSTEM-RELATED DISEASES

Publications (2)

Publication Number Publication Date
FR2830762A1 FR2830762A1 (en) 2003-04-18
FR2830762B1 true FR2830762B1 (en) 2004-10-22

Family

ID=8868365

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0113342A Expired - Fee Related FR2830762B1 (en) 2001-09-07 2001-10-16 USE OF A PROTEIN FROM THE CRMPS FAMILY FOR THE TREATMENT OF IMMUNE SYSTEM-RELATED DISEASES

Country Status (1)

Country Link
FR (1) FR2830762B1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2759701B1 (en) * 1997-02-19 1999-06-04 Inst Nat Sante Rech Med USE OF ULIP PROTEINS IN THE DIAGNOSIS AND THERAPY OF CANCER AND PARANEOPLASTIC NEUROLOGICAL SYNDROMES
FR2805540B1 (en) * 2000-02-29 2004-04-09 Inst Nat Sante Rech Med NOVEL HUMAN ULIP PROTEIN AND ITS USE IN THE DIAGNOSIS AND THERAPY OF CANCER AND NEUROLOGICAL PARANEOPLASTIC SYNDROMES

Also Published As

Publication number Publication date
FR2830762A1 (en) 2003-04-18

Similar Documents

Publication Publication Date Title
CH1143977H1 (en) 2-Oxy-benzoxazine-4-ones for the treatment of obesity
MA26992A1 (en) PHENETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
FR13C0060I2 (en) FLUORO-SUBSTITUTED OMEGA-CARBOXYARYLDIPHENYLUREA FOR THE TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS
FR2840804B1 (en) SYSTEM FOR THE TREATMENT OF OBESITY AND IMPLANT FOR SUCH A SYSTEM
FR16C0041I2 (en) CHIMERIC COAGULATION FACTOR PROTEINS FOR THE TREATMENT OF A HEMOSTASIS DISORDER
EP1604664A4 (en) MEDICINE FOR THE PREVENTION AND TREATMENT OF ARTERIOSCLEROSIS AND HYPERTENSION
ATE417037T1 (en) DIARYLUREA DERIVATIVES SUITABLE FOR THE TREATMENT OF PROTEIN KINASE-DEPENDENT DISEASES
MA27334A1 (en) USE OF IKB KINASE INHIBITORS IN THE TREATMENT OF PAIN
EP1499333A4 (en) METHODS RELATING TO THE TREATMENT OF INTESTINAL OCCLUSION
FR14C0028I2 (en) PHENETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
DE60235719D1 (en) WOMEN'S HYGIENIC PRODUCTS FOR THE ADMINISTRATION OF MEDICINAL PRODUCTS
FR2833490B1 (en) COSMETIC USE OF AT LEAST ONE HYDROPHOBIN FOR THE TREATMENT OF KERATINIC MATERIALS AND COMPOSITIONS IMPLEMENTED
EE04156B1 (en) Sulfonamides for the treatment of endothelin-mediated diseases
DE60218493D1 (en) SUBSTITUTED 7-AZA-Ä2.2.1ÜBICYCLOHEPTANE FOR THE TREATMENT OF DISEASES
EE200300214A (en) Sulfonamides for the treatment of endothelin-mediated diseases
FR22C1033I1 (en) Use of dihydroimidazolones for the treatment of dogs
FR2854074B1 (en) USE OF IVERMECTIN FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS
MA26951A1 (en) PYRAZOLE DERIVATIVES FOR THE TREATMENT OF VIRAL DISEASES
DZ3014A1 (en) Medicines for the treatment of hypertension.
EP1534696A4 (en) THERAPEUTIC COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIC CONDITIONS
EP1416957A4 (en) TREATMENT OF IMMUNE DISEASES AND B-CELL DISEASES
EP1749532A4 (en) MEDICAMENT FOR HEALING OR TREATMENT OF INJURY
FR2857597B1 (en) USE OF PEPTIDE CONJUGATES FOR THE PREPARATION OF COMPOSITIONS FOR THE PREVENTIVE AND CURATIVE TREATMENT OF ALOPECIA.
FR2830762B1 (en) USE OF A PROTEIN FROM THE CRMPS FAMILY FOR THE TREATMENT OF IMMUNE SYSTEM-RELATED DISEASES
WO2003055440A8 (en) Compositions and methods for the treatement of immune related diseases

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130628